coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    South Tandridge PCN, Tandridge · Health Inequalities Profile

    PCN U02049 · NHS Surrey Heartlands Integrated Care Board; NHS Surrey and Sussex Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    34,496

    Registered population

    56.4% aged 18–64

    23.7%

    Aged 65+

    ICB 18.8% · England 17.9%

    6.8%

    Ethnic minority (non-White)

    2.4% Asian · England 9.6%

    0.0%

    In IMD quintile 1

    ICB 0.8% · England 21.0%

    0

    Core20 residents (est.)

    Resident basis; registered basis 0 · see page 3

    5,596

    Hypertension register

    +11.76% in 3 yrs · England +5.60%

    226

    SMI register

    24.6% of Tandridge's

    578

    COPD register

    Reviews +1.14% in 3 yrs

    Forecast to 2030

    7,441

    Hypertension patients, 2049

    +1,845 on today

    66.1%

    QRISK ≥20% on statins, 2049

    +2.54pp over 3 yrs

    7.3%

    Cancer prevalence, 2049

    England 4.5%

    Three things the board should see

    -6.4%
    Under-80 blood pressure control fell over three years.

    Control in under-80s sits at 65.3% (England 67.8%) after a -6.4% change over 2023 to 2025 against +3.2% in England.

    59.3%
    Annual asthma reviews trail local and national benchmarks.

    Only 59.3% had a review (Tandridge 66.4%, ICB 65.6%, England 65.7%), leaving about 850 of 2,096 asthma patients unreviewed after a -5.1% three-year change.

    +11.2%
    Non-frail diabetes HbA1c control outpaced comparator growth.

    HbA1c control at or below 58 mmol/mol rose +11.2% over 2023 to 2025 (Tandridge +4.0%, ICB +3.6%, England +4.4%), reaching 55.6% against 57.4% nationally.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Older patients comprise 23.7% of the list alongside 17 catchment care homes

    Across 34,496 registered patients, 23.7% (8,161) are aged 65+, above Tandridge (20.9%), the ICB (18.8%) and England (17.9%). Working-age adults (18–64) represent 56.4% and children (0–17) 19.9%. Census resident data shows 93.2% White background (Tandridge 89.4%, ICB 85.3%, England 81.1%), alongside 2.4% Asian and 1.1% Black residents. Unverified ONS projections model +5.6% list growth to 2030 (Tandridge +6.0%, ICB +4.9%, England +2.3%). Registered lists and Census resident catchments have different population bases.

    Age profile

    0–1719.9%
    18–6456.4%
    65+23.7%

    65+: ICB 18.8%, England 17.9%

    Ethnicity

    White93.2%
    Mixed2.7%
    Asian2.4%
    Black1.1%
    Other0.6%

    Older people · falls rows are Tandridge local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Tandridge LA)2,4552,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)55.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Tandridge LA)1,2339819552024/25
    Falls deaths, all ages, per 100,000 (Tandridge LA)12.014.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 0.0% across all practices, with average IMD decile 6.8

    No registered patients (0.0%, 0 estimated patients) live in Core20 areas (the most deprived 20% of areas nationally), matching Tandridge (0.0%), below NHS Surrey Heartlands Integrated Care Board (0.8%), and 21.0 percentage points below England (21.0%). Average IMD decile is 6.8 (Tandridge 7.1, ICB 7.9, England 5.5). By practice, Core20 share is 0.0% across Pond Tail Surgery (IMD decile 5.3), Lingfield Surgery (decile 6.6), and Oxted Health Centre (decile 8.0). With 0.0% Core20 reach, tackling local inequalities requires prioritising inclusion health cohorts over area-based outreach.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Pond Tail0.0% · 0 patients
    Lingfield0.0% · 0 patients
    Oxted0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    226

    SMI register

    0.65% recorded prevalence

    274

    Learning disability register

    0.79% recorded prevalence

    17

    Care homes, 572 beds

    In the PCN catchment

    8.3%

    Provide unpaid care

    Tandridge, Census 2021

    The PCN records 274 learning disability patients (0.8%; Tandridge 0.7%, ICB 0.5%, England 0.6%) and 226 severe mental illness patients (0.7%; Tandridge 0.8%, ICB 0.8%, England 1.0%), alongside 17 catchment care homes (572 beds). Gypsy or Irish Traveller residents comprise 0.6% (England 0.1%). Sites and bed capacity do not establish occupancy or registered care-home residents.

    Severe mental illness: physical health checks

    Across 226 severe mental illness patients, annual blood pressure checks reached 78.9% (England 83.4%) and BMI checks reached 78.3% (England 82.1%). Gaps may reflect recall barriers, which dedicated outreach review would test.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    5,596

    Hypertension register

    +11.76%

    Register growth, 3 yrs

    Tandridge +6.34% · England +5.60%

    −4.44pp

    BP control, under 80

    ≤140/90 · +0.20pp aged 80+

    +1,845

    More patients by 2030

    Forecast 7,441 (20.06%)

    Hypertension case-finding and control

    Hypertension register prevalence is 16.1% (5,596 patients), above England (15.2%), Tandridge (15.3%) and NHS Surrey Heartlands Integrated Care Board (14.3%), having expanded +11.8% over 2023 to 2025 (England +5.6%). However, recent blood pressure recording fell 2.9% over 2023 to 2025 (England +3.6%) to 85.3% (England 90.0%). Blood pressure control in patients aged under 80 dropped 6.4% over 2023 to 2025 (England +3.2%) to 65.3% (England 67.8%), spanning from 61.8% at Pond Tail Surgery and 63.8% at Oxted Health Centre to 70.0% at Lingfield Surgery. Control for ages 80+ is 75.3% (England 81.2%). Declining control could reflect routine recall capacity lagging register growth, which a clinical capacity audit would test.

    Lipids and statins

    For patients with QRISK ≥ 20%, lipid-lowering therapy uptake is 60.7%, below England (63.6%) but above Tandridge (58.5%). Uptake among CKD patients is 62.9% (England 70.3%). Lower uptake than England may indicate treatment gaps, which a targeted prescribing review would test.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 202643,656£2.70£2.24£1.86£117,871
    Cardiovascular (all), 202563,400£4.82£4.74£3.33£305,588

    In 2026, 43,656 lipid-regulating items were prescribed at £2.70 per item, above England (£1.86), Tandridge (£2.36) and NHS Surrey Heartlands Integrated Care Board (£2.24). This unit-cost difference represents £36,671 more than at England's unit cost across 43,656 items. Higher unit costs could reflect product choice rather than prescribing inefficiency, which a formulary audit would test.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.07%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +1.04%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 6.4% (2,096 patients). Over 2023 to 2025, annual asthma reviews fell 5.1% (England +4.4%) to 59.3% (England 65.7%, Tandridge 66.4%, ICB 65.6%), leaving about 850 patients unreviewed, ranging from 51.9% at Oxted Health Centre to 70.3% at Lingfield Surgery. Second-hand smoke recording for ages 6–19 is 67.8% (England 78.8%). COPD prevalence is 1.7% (England 1.9%), and COPD reviews reached 71.6% (England 76.4%). Review shortfalls could reflect recall capacity constraints, which an appointment audit would test.

    Cancer register and children's immunisation

    The cancer register comprises 2,051 patients (5.9% prevalence vs England 3.8%). For childhood immunisations, 6-in-1 coverage at 12 months reaches 97.4% and MMR dose 1 at age 5 reaches 95.6% (meeting the 95.0% target). However, MMR dose 2 coverage at age 5 is 85.7%, reflecting a 9.9 pp difference between first and second dose across South Tandridge PCN.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months97.4%

    England 91.0%

    6-in-1 complete primary course at 24 months92.2%

    England 92.2%

    MMR dose 1 at 24 months87.0%

    England 88.3%

    MMR dose 2 at age 585.7%

    England 82.8%

    4-in-1 pre-school booster at age 584.6%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    61.4%

    Surrey Heartlands ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~650

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Surrey Heartlands ICBEnglandNo usable stageStaged cancers
    Prostate65.7%53.2%18%1,044
    Breast88.2%85.4%27%798
    Bowel48.1%47.0%18%626
    Lung33.2%33.8%17%497
    Skin cancer89.8%87.8%19%384

    In 2022, 61.4% of staged cancers across NHS Surrey Heartlands ICB were diagnosed at stage 1 or 2 (2,955 of 4,810 known-stage cases), above England (55.3%) but below the 75.0% national ambition by 13.6 pp. Known staging covered 67.7% of registered cancers (4,810 of 7,106). Closing this gap requires about 650 extra early-stage diagnoses yearly system-wide. Locally, PCN cancer prevalence is 5.9% (2,051 patients), rising +11.5% over 2023 to 2025 (England +9.0%). Cervical screening uptake is 75.7% (England 66.8%), but fell 2.3% over 2023 to 2025 (England -1.0%). ICB staging reflects wider system patterns, not PCN performance. Sustaining early detection requires protecting routine screening uptake as register prevalence expands.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional) at Surrey and Sussex Healthcare NHS Trust, cancer 62-day referral to treatment was 70.0% against the 85.0% standard (NHS Surrey and Sussex ICB 71.5%, England 71.2%), with King's College Hospital NHS Foundation Trust at 70.1% and Croydon Health Services NHS Trust at 69.9%. The trust achieved the 28-day faster diagnosis standard at 77.7% (standard 75.0%; ICB 79.3%, England 79.3%) and the 31-day standard at 96.2%. Diagnostic waits show 28.5% waiting 6+ weeks (England 23.1%), including 32.3% for non-obstetric ultrasound. Provider performance reflects acute capacity, not PCN delivery.

    Pathways within standard (%)Surrey and Sussex HealthcareKing's CollegeCroydon HealthSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)77.7480.6883.2279.2979.32
    31-day treatment (96%)96.2096.6899.0690.4592.50
    62-day referral to treatment (85%)69.9770.1569.8871.5171.16
    Diagnostic waits over 6 weeks (%)Surrey and Sussex HealthcareKing's CollegeCroydon HealthEngland
    MRI27.5321.220.2621.40
    CT18.4922.607.699.92
    Echocardiography43.7814.393.6028.48
    Colonoscopy15.1141.8121.8030.83
    Gastroscopy21.0635.9817.9429.02
    All 15 DM01 tests28.5019.153.5123.14
    Community services activitySurrey residentsSurrey and Sussex ICB
    Care contacts109,530309,615
    Referrals28,70066,930
    Patients with a contact33,51085,660

    Community services (residents of Surrey), Jun 2026 (provisional). In Jun 2026 (provisional), 33,510 Surrey residents had a community care contact, generating 109,530 contacts and 66,060 care activities. Adults aged 65+ accounted for 69.6% of these contacts. Across NHS Surrey and Sussex Integrated Care Board, 309,615 care contacts and 316,320 activities were recorded. These provisional experimental figures describe submitting providers rather than South Tandridge PCN activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Easy phone access spans 31.6 percentage points across the three member practices

    In 2025/26, overall QOF achievement was 100.0% at Lingfield Surgery, 98.0% at Pond Tail Surgery, and 95.3% at Oxted Health Centre, compared with 92.5% across England. Vaccination and immunisation achievement spanned 35.6 percentage points, from 64.4% at Oxted Health Centre to 100.0% at Lingfield Surgery. At Lingfield Surgery, the vaccination and immunisation domain personalised care adjustment rate was 15.4%.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Pond Tail Surgery1050.073.5%66.8%91.7%
    Oxted1120.041.9%61.6%68.3%
    Lingfield Surgery1350.045.8%71.5%67.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNTandridgeAssetPCNTandridge
    Care homes (catchment)17 (572 beds)n/aSchools (catchment)45n/a
    Children's centres26Places of worship3561
    Libraries24Food banks (VCS)n/a2
    Homelessness support (VCS)0no dataDay centres (VCS)45
    Children and young people (VCS)11Carers support groups (VCS)33
    Primary schools (LA maintained)914Primary academies511

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension recall and BP control

    Hypertension grew +11.8% over 2023 to 2025 to 5,596 patients (16.1%), while under-80 BP control fell 6.4% (England +3.2%) to 65.3% (England 67.8%, ICB 68.1%, Tandridge 67.7%), and recent BP recording fell 2.9% to 85.3%. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Annual asthma review recall capacity

    Asthma annual reviews fell 5.1% over 2023 to 2025 (England +4.4%) to 59.3% across the 2,096-patient register (England 65.7%, Tandridge 66.4%, ICB 65.6%), leaving about 850 patients without a recorded review. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Pre-school MMR2 and booster recall

    In Q1 2025/26 (cohort 91), age-5 MMR1 coverage reached 95.6% (above the 95.0% target), but MMR2 was 85.7% (below target by 9.3 pp; 9.9 pp dose difference) and 4-in-1 booster was 84.6%. Low cost, quick to run.

    Evidence base: coverage against the 95% target is the direct measure of programme delivery and catch-up need; where coverage clusters low, that decides whether catch-up is organised at practice, PCN, school or outreach level.

    Policy anchor: 10 Year Health Plan, shift from sickness to prevention.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Frailty and older age planning (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    SMI physical health outreach (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall alignment (p6)MMR dose 2 coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake review (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Telephony and triage review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension recall and BP control (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Annual asthma review recall capacity (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN & Practice
    Option 3 · Pre-school MMR2 and booster recall (p12)MMR dose 1 coverage at age 5 · MMR dose 2 coverage at age 5 · 4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15